Skip to main content
. 2013 May 13;8(5):e62950. doi: 10.1371/journal.pone.0062950

Table 3. Main results of eligible studies evaluating RARβ2 methylation and pathologic stage/Gleason score in prostate cancer.

Variables pa OR 95% CI Heterogeneity
X2 P I2
stage 5 0.67 0.40–1.08 1.75 0. 782 0.0%b
Gleason score 8 0. 54 0.28–1.04 17.91 0. 012 60. 9%
a

Number of comparisons.

b

Between group heterogeneity not calculated; only valid with inverse variance method.